Connected Healthcare Market Research Report- Global Forecast to 2022

Connected Healthcare Market Research Report- Global Forecast to 2022

ID: MRFR/HC/1360-CRR | December, 2016 | Region: Global | 152 pages | Cooked Research Reports

Global Connected Healthcare Market Information, by type (m-health devices, m-health services and e-prescription), by application (monitoring applications, diagnosis & treatment, education and awareness, healthcare management, wellness & prevention and others) - Forecast to 2022


Market Synopsis of Global Connected Healthcare Market:
Market Scenario:
Connected healthcare solutions consolidate information from many different spheres of a person’s world to give a more complete picture of their health that includes biological, genetic, medical, lifestyle and sentiment/mood data. These solutions puts the patient at the centre of the healthcare system gathering, linking and interpreting information from many different sources to enable informed, patient-centred care decisions. 


The global market for Connected Healthcare is expected to reach USD 105.33 billion by the end of the forecasted period and is expected to grow at a CAGR of 30.2%.


Study Objectives Global Connected Healthcare Market:



  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global connected healthcare market.

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by type, by application and other sub segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.


 Global Connected Healthcare Market Share, by type, 2015 (%):



Intended Audience



  • Medical device manufacturers

  • Medical device suppliers

  • Government Research Laboratory

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories


Key Finding



  • The global connected healthcare market and is expected to reach US 105.33 billion by 2022.

  • Regionally, North America holds the largest market share for global connected healthcare market and is expected to grow at a CAGR of 28.75% by 2022.

  • Asia Pacific market is expected to be the fastest growing market, and expected to reach at USD 24.07 billion by 2022.

  • On the basis of type, M-health services segment holds largest market share.


Key Players for Global Connected Healthcare Market:
Some of the key players in this market are: Agamatrix, Inc. (US), Airstrip Technology (US), AliveCor Inc. (Australia), Allscripts (US), Athenahealth Inc. (US), Boston Scientific Corporation (US), Cerner (US), Koninklijke Philips N.V. (Netherlands), GE healthcare (UK), Qualcomm (US), Medtronics (Ireland) and others.


Segments:
Global Connected Healthcare market has been segmented on the basis of type which comprises of M-health devices, M-health services and E-prescription. On the basis of application; market is segmented into Monitoring Applications, Diagnosis & Treatment, Education and Awareness, Healthcare Management, Wellness & Prevention and others.


Regional Analysis of Global Connected Healthcare Market:
Globally North America is the largest market for Connected Healthcare. The North American market for Connected Healthcare is expected to reach at USD 37.38 billion by the end of the forecasted period.


Europe is the second-largest market for Connected Healthcare which is expected to grow at a CAGR of 30.48%. Asia pacific region is expected to be fastest growing region in Connected Healthcare market.



North America


  • US

  • Canada


Europe


  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe


Asia


  • Japan

  • China

  • India

  • Rest of Asia-Pacific


Australia
Republic of Korea
Middle East & Africa

The report for Global Connected Healthcare Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
TABLE OF CONTENTS

2.1 Scope of Study

2.2 Research Objective

2.3 Assumptions & Limitations

2.3.1 Assumptions

2.3.2 Limitations

2.4 Market Structure

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

4.1 Introduction

4.2 Drivers

4.2.1 Connected Healthcare applications has increased the involvement of patient population

4.2.2 Increasing use of Smartphones and wearable devices into healthcare has led to the growth of the market

4.2.3 Cost effectiveness and Patients’ Convenience will drive the connected healthcare market

4.2.4 Continuous increase in Lifestyle Disease has led to the development of personalized healthcare solutions

4.3 Restraints

4.3.1 Increasing privacy and cybercrimes restraint the growth of connected healthcare market

4.3.2 Lack of Awareness about the possible applications of connected healthcare

4.3.3 Reluctance to share information regarding the health has limit the growth of the market

4.4 Opportunities

4.4.1 Growing partnership between the companies has become the entrance gateway for new firms

4.4.2 Introduction of connected healthcare in developing economies will boost the growth of the connected healthcare

4.5 Challenges

4.5.1 Low rate of literacy and language barriers in low- and middle-income countries (LMICs) is a big challenge for the connected healthcare solutions

4.5.2 Potential risk of Hardware or Software failure will barred the growth of the market

4.5.3 Stringent Regulations and Standards will restraining the growth of the mar

5.1 Connected Healthcare Device: Porter’s Five Force Analysis

5.1.1 Bargaining Power of Buyer

5.1.2 Bargaining Power of Supplier

5.1.3 Threat from substitute

5.1.4 Threat from a New Entrant

5.1.5 Intensity of Competitive Rivalry

5.2 Value Chain Analysis

5.2.1 Device Manufacturers

5.2.2 App Developers

5.2.3 Network providers/ Mobile operators

5.2.4 Healthcare providers and Pharmaceuticals

5.2.5 Patients

6.1 Introduction

6.2 M-Health Services

6.2.1 Mobile health Apps and Content Solution

6.2.1.1 Software

6.2.1.2 Big Data

6.2.2 Network and Services/ Mobile operators

6.2.3 Healthcare Providers and Pharmaceuticals

6.2.3.1 Healthcare providers

6.2.3.2 Pharmaceuticals

6.3 M-Health Devices

6.3.1 Medical Devices

6.3.1.1 SMBG

6.3.1.2 Blood Pressure Monitor

6.3.1.3 Cardiac Monitors

6.3.1.4 Pulse Oximeter

6.3.1.5 Other Medical Devices

6.3.2 Wearable Devices

6.3.2.1 Hand Worn Products

6.3.2.1.1 Smart Watch

6.3.2.1.2 Wrist Wear

6.3.2.2 Head Worn Products

6.3.2.2.1 AR/VR HMD/HUD

6.3.2.2.2 Others

6.3.2.3 Body worn products

6.3.2.3.1 Smart Textile

6.3.2.3.2 Wearable Patch

6.3.2.3.3 Others

6.3.3 Connected Drug Delivery Systems

6.3.3.1 Auto-injectors

6.3.3.2 Inhalers

6.4 E-Prescription

7.1 Introduction

7.2 Monitoring Applications

7.3 Diagnosis & Treatment

7.4 Education and Awareness

7.5 Healthcare Management

7.6 Wellness & Prevention

7.7 Other Applications

8.1 Introduction

8.2 North America

8.2.1 Introduction

8.2.2 U.S.

8.2.3 Canada

8.3 Europe

8.3.1 Introduction

8.3.2 Germany

8.3.3 France

8.3.4 U.K.

8.3.5 Italy

8.3.6 Spain

8.4 Asia-Pacific

8.4.1 Introduction

8.4.2 Japan

8.4.3 China

8.4.4 India

8.4.5 Australia

8.4.6 Republic of Korea

8.5 Middle East & Africa

8.5.1 Introduction

8.5.2 Africa

8.5.3 Middle East

9.1 Introduction

9.1.1 Partnerships, Agreements and Collaborations

9.1.2 Product Development and Launch

9.1.3 Approvals

9.1.4 Acquisitions

9.1.5 Award & Recognition

9.1.6 Others

10.1 Agamatrix, Inc.

10.1.1 Company Overview

10.1.2 Product/Business Segment Overview

10.1.3 Financial Overview

10.1.4 Key Development

10.1.5 SWOT Analysis

10.2 AirStrip Technologies

10.2.1 Company Overview

10.2.2 Product/Business Segment Overview

10.2.3 Financial Overview

10.2.4 Key Development

10.2.5 SWOT Analysis

10.3 AliveCor Inc.

10.3.1 Company Overview

10.3.2 Product/Business Segment Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Allscripts

10.4.1 Company Overview

10.4.2 Product/Business Segment Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Apple Inc.

10.5.1 Company Overview

10.5.2 Product/Business Segment Overview

10.5.3 Financial Overview

10.5.4 SWOT Analysis

10.6 Athenahealth, Inc.

10.6.1 Company Overview

10.6.2 Product/Business Segment Overview

10.6.3 Financial Overview

10.6.4 Key Development

10.6.5 SWOT Analysis

10.7 Boston Scientific Corporation

10.7.1 Company Overview

10.7.2 Product/Business Segment Overview

10.7.3 Financial Overview

10.7.4 Key Development

10.7.5 SWOT Analysis

10.8 Cerner

10.8.1 Company Overview

10.8.2 Product/Business Segment Overview

10.8.3 Financial Overview

10.8.4 Key Development

10.8.5 SWOT Analysis

10.9 GE Healthcare

10.9.1 Company Overview

10.9.2 Product/Business Segment Overview

10.9.3 Financial Overview

10.9.4 Key Development

10.9.5 SWOT Analysis

10.1 Honeywell Life Care Solutions

10.10.1 Company Overview

10.10.2 Product/Business Segment Overview

10.10.3 Financial Overview

10.10.4 Key Development

10.10.5 SWOT Analysis

10.11 Medtronics

10.11.1 Company Overview

10.11.2 Product/Business Segment Overview

10.11.3 Financial Overview

10.11.4 Key Development

10.11.5 SWOT Analysis

10.12 Microsoft

10.12.1 Company Overview

10.12.2 Product/Business Segment Overview

10.12.3 Financial Overview

10.12.4 SWOT Analysis

10.13 Persistent Systems

10.13.1 Company Overview

10.13.2 Product/Business Segment Overview

10.13.3 Financial Overview

10.13.4 Key Development

10.13.5 SWOT Analysis

10.14 Koninklijke Philips N.V.

10.14.1 Company Overview

10.14.2 Product/Business Segment Overview

10.14.3 Financial Overview

10.14.4 Key Development

10.14.5 SWOT Analysis

10.15 Qualcomm

10.15.1 Company Overview

10.15.2 Product/Business Segment Overview

10.15.3 Financial Overview

10.15.4 Key Development

10.15.5 SWOT Analysis

10.16 Sanofi

10.16.1 Company Overview

10.16.2 Product/Business Segment Overview

10.16.3 Financial Overview

10.16.4 Key Development

10.16.5 SWOT Analysis

10.17 Vivify Health, Inc.

10.17.1 Company Overview

10.17.2 Product/Business Segment Overview

10.17.3 Financial Overview

10.17.4 SWOT Analysis